German drug and chemicals giant Bayer has made an unsolicited takeover offer for Monsanto, the world's biggest seed company.
Carl Tannenbaum, chief economist at Northern Trust, looks at the merger space with specific comment on the potential Bayer, Monsanto deal.
European markets finished in the red on Thursday, as a renewed decline in oil prices, a sharp fall in miners and mixed earnings capped gains in the region.
European equities finished mixed as investors digested a whole raft of new earnings, ahead of a number of important central bank meetings this week.
Inventor of aspirin and maker of Yasmin birth control pills says it still expects adjusted EBITDA to increase this year.
A look at a number of drugs that revolutionized medicine and provided new treatments for widespread ailments and disease.
European shares ended Monday lower as the oil price came off its session lows.
European markets posted strong gains by Thursday's close, as investors cheered on a positive set of corporate earnings, rather than dwelling on oil.
European markets ended mixed to slightly lower on Wednesday as investors tried to digest what was happening with commodities.
It's a high risk business, says Marijn Dekkers, Bayer CEO, discussing price controls and the huge expense associated with innovating and developing new drugs.
European stocks closed mixed to lower on Thursday, as start-of-quarter enthusiasm petered out among investors and telecom stocks weighed on investor sentiment.
Kevin Kelly, CIO of Recon Capital Partners, explains why he loves the German company's stock.
Chipotle Mexican Grill's new GMO-free menu claims have lured diners, but it has some consumers crying foul.
European markets finished higher on Monday following a rally in U.S. stocks as the oil price surged as much as 2 percent.
DAX all folks
European stocks finished higher on Wednesday after a bumper day of earnings, while investors awaited news from a two-day policy meeting of the U.S. Federal Reserve.
The CEO of German drugmaker Bayer has quashed any talk of acquiring its competitor Syngenta, which is being pursued by U.S. firm Monsanto.
Marijn Dekkers, CEO of Bayer, says Syngenta wouldn't be a logical acquisition target for Bayer.
European equities tumbled on Wednesday to close sharply lower as investors reacted to sharp gains in the euro against the dollar.
European equities rallied on Thursday, closing nearly 1 percent higher as investors reacted to a raft of corporate earnings and fresh economic data.